FORE Biotherapeutics closes $75M financing to accelerate development of plixorafenib 24-Aug-2023 By Liza Laws FORE Biotherapeutics yesterday (August 23) announced the closing of its $75 million (£59 million) series D financing, led by the SR One and co-led by Medicxi and joined by existing investors.